Genome-wide analysis of histone marks identifying an epigenetic signature of promoters and enhancers underlying cardiac hypertrophy.
about
Epigenetics in heart failure phenotypesEpigenetic regulation by histone demethylases in hypoxiaThe role of O-GlcNAc transferase in regulating the gene transcription of developing and failing heartsClinical applications of epigenetics in cardiovascular disease: the long road aheadHeart failure: advanced development in genetics and epigeneticsEpigenetic mechanisms in heart development and diseaseEpigenetic silencing of TIMP4 in heart failure.Photosynthetic Genes and Genes Associated with the C4 Trait in Maize Are Characterized by a Unique Class of Highly Regulated Histone Acetylation Peaks on Upstream Promoters.Decoding the complex genetic causes of heart diseases using systems biologyEpigenomic and transcriptomic approaches in the post-genomic era: path to novel targets for diagnosis and therapy of the ischaemic heart? Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart.Heart Failure and MEF2 Transcriptome Dynamics in Response to β-Blockers.Epigenetic switch at atp2a2 and myh7 gene promoters in pressure overload-induced heart failure.Epigenetic mechanisms in heart failure pathogenesisEpigenetic regulation of cardiac myocyte differentiation.Epigenomes: the missing heritability in human cardiovascular disease?How the proteome packages the genome for cardiovascular development.Readers, writers, and erasers: chromatin as the whiteboard of heart diseaseExtrapolating histone marks across developmental stages, tissues, and species: an enhancer prediction case studyThe PTIP-Associated Histone Methyltransferase Complex Prevents Stress-Induced Maladaptive Cardiac Remodeling.Functional importance of cardiac enhancer-associated noncoding RNAs in heart development and diseaseHTLV-1 bZIP Factor Impairs Anti-viral Immunity by Inducing Co-inhibitory Molecule, T Cell Immunoglobulin and ITIM Domain (TIGIT).Kruppel-like factor 4 is critical for transcriptional control of cardiac mitochondrial homeostasis.HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes.It's Time for An Epigenomics Roadmap of Heart FailureEpigenetic regulation in heart failure.Reciprocal Regulation of the Cardiac Epigenome by Chromatin Structural Proteins Hmgb and Ctcf: IMPLICATIONS FOR TRANSCRIPTIONAL REGULATION.DNA hydroxymethylation controls cardiomyocyte gene expression in development and hypertrophy.DOT1L-mediated H3K79me2 modification critically regulates gene expression during cardiomyocyte differentiation.The Function of the MEF2 Family of Transcription Factors in Cardiac Development, Cardiogenomics, and Direct Reprogramming.The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy.Genomic architecture of sickle cell disease in West African children.Integrated mechanisms of CaMKII-dependent ventricular remodeling.Chromatin modifications remodel cardiac gene expression.Epigenetics in cardiac development, function, and disease.BET-ting on chromatin-based therapeutics for heart failure.Epigenetic regulation and heart failure.Epigenetic modifications and noncoding RNAs in cardiac hypertrophy and failure.High Resolution Mapping of Chromatin Conformation in Cardiac Myocytes Reveals Structural Remodeling of the Epigenome in Heart FailureGlobal MEF2 target gene analysis in cardiac and skeletal muscle reveals novel regulation of DUSP6 by p38MAPK-MEF2 signaling.Phenylephrine-induced cardiac hypertrophy is attenuated by a histone acetylase inhibitor anacardic acid in mice.
P2860
Q26747565-F1CCD807-A21F-488E-8CBB-2AF7D4FC2902Q26825704-5F990309-91D1-41C9-BE3B-5B2ACD94EEF2Q27005703-9D9D1CBB-F8EF-4637-B4DD-22968E513177Q27008290-7DA52DDE-90D6-482E-8F39-316716B97AB4Q28080771-90768176-F05E-4D46-96AB-E5FEC3D299CAQ28081134-07818299-88C1-49C4-A1F9-C1780A763ACFQ30371061-3EC50FA3-7D5D-402F-B507-4EC64ACE165FQ33361010-F11521F0-C1B0-4797-9406-A7A97259A6FCQ33639681-A0BC12B9-0BA3-4F76-A686-F10363B2A313Q33705752-4661D5CB-F1F3-49FE-ADEE-12D2A7F7EB94Q33860807-94015E8D-ACAA-4568-98B5-3E29D85F0142Q34121851-993B22CB-2811-4E25-BBEF-244B66279812Q34212728-3AE2BD25-484E-4399-8F30-D387580CE9BEQ34449181-D2937474-4E74-40F0-B185-FA3A43B7172EQ34710223-1F715252-D089-4D88-8B5D-E225C9A92E1EQ34730243-0FA8B051-5206-428A-A31B-5C1AB715B87DQ35234488-66D2867C-9AF4-4775-BED1-06D95E78F3A0Q35576034-D8003DCC-415B-4DEF-9386-4E27AB5EFBA8Q35639445-79C00BCC-16D1-4036-9A41-B9437FEAD81CQ35651402-CE849390-BECD-4A1B-B59B-718CF767074FQ35886890-94D62E42-FA85-4F09-96FE-63B4CF0B7E66Q36106100-2358B174-F1F3-48ED-8103-1B0EF3C533CBQ36212830-10B8DB2C-D17A-49E2-BA46-E3BFE8224DDDQ36613033-217AC55A-523E-48DF-A9D9-233964D805F7Q37114038-C3F380B4-A681-4774-A7A5-FE8B26C63376Q37117250-6734A745-8366-46FA-91FB-38B114657ABDQ37157067-CB2083A2-5ED4-483F-90A8-A1DE1C1B9CA9Q37179299-49FEC7A5-3210-447D-93EC-5AC6D286E0AEQ37248495-DB396480-89A0-4219-8273-7DAF8047BF6CQ37317831-6347E86D-5B9A-4A23-B197-04CF508B7C71Q37584394-68A934C9-6DA5-4A4B-AF12-8FC05E63AE62Q38198633-E225A792-9E07-4216-BA22-889DB0537D5CQ38210525-7C22FF35-4D3A-4FD7-A3C3-0482CBB4E8E6Q38210945-5599722F-805A-4A75-9072-EBCDE5AC2AF9Q38212530-D4F277F0-3C47-482F-A7FB-1DA58CBDC652Q38232304-B2C5F959-F3A6-49E6-BC59-2A10CD312B96Q38473339-6B28FCA1-CD9E-4030-965C-61FA8E7DBEF7Q38643488-CB0B893C-810A-4DC7-8AE9-EEF63E9B9504Q38956956-A5EB830D-E4B5-4902-BC01-7848515CF683Q38963028-036B0225-9302-48AC-A25D-27E5EEA0A767
P2860
Genome-wide analysis of histone marks identifying an epigenetic signature of promoters and enhancers underlying cardiac hypertrophy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Genome-wide analysis of histon ...... nderlying cardiac hypertrophy.
@en
Genome-wide analysis of histon ...... nderlying cardiac hypertrophy.
@nl
type
label
Genome-wide analysis of histon ...... nderlying cardiac hypertrophy.
@en
Genome-wide analysis of histon ...... nderlying cardiac hypertrophy.
@nl
prefLabel
Genome-wide analysis of histon ...... nderlying cardiac hypertrophy.
@en
Genome-wide analysis of histon ...... nderlying cardiac hypertrophy.
@nl
P2093
P2860
P50
P356
P1476
Genome-wide analysis of histon ...... underlying cardiac hypertrophy
@en
P2093
Alessandro Guffanti
Gerd Hasenfuss
Michael V G Latronico
Valentina Viganò
P2860
P304
20164-20169
P356
10.1073/PNAS.1315155110
P407
P50
P577
2013-11-27T00:00:00Z